Silent Threat Below the Surface: How HIV and Its Treatments Can Quietly Compromise Your Kidneys — and How to Stay Ahead of It

For many people living with HIV, the conversation with their care team centers on viral load, CD4 counts, cardiovascular risk, and bone density. These are all legitimate and important concerns. But one organ system rarely receives the attention it deserves until the damage is already well underway: the kidneys.

Renal disease is not a rare or fringe complication in the HIV-positive population. Research consistently shows that people living with HIV are significantly more likely to develop chronic kidney disease (CKD) than their HIV-negative peers — and the reasons are more complex than many patients realize. The virus itself plays a role. Certain antiretroviral medications play a role. And longstanding disparities in care access mean that some communities bear a disproportionately higher burden of this risk.

Understanding what is happening inside your kidneys — and why your routine labs may not be telling the full story — could be one of the most important steps you take toward long-term health.

Why the Kidneys Are Uniquely Vulnerable in HIV

The kidneys perform an extraordinary amount of work. Every day, these two fist-sized organs filter roughly 200 liters of blood, regulate fluid balance, manage blood pressure, and clear metabolic waste from the body. That constant workload makes them highly sensitive to inflammatory stress — and HIV is, at its core, a chronic inflammatory condition.

Even in people whose viral load is fully suppressed through antiretroviral therapy (ART), low-level immune activation can persist. This ongoing inflammation contributes to endothelial dysfunction, microvasculature damage, and direct injury to the glomeruli — the tiny filtering units within the kidney. One specific condition, HIV-associated nephropathy (HIVAN), predominantly affects Black Americans living with HIV and can progress rapidly to kidney failure if not identified early. Genetic factors, including variants in the APOL1 gene, significantly elevate this risk in people of African ancestry.

Beyond the virus itself, certain antiretroviral drugs have well-documented nephrotoxic potential. Tenofovir disoproxil fumarate (TDF), a nucleotide reverse transcriptase inhibitor used widely in both treatment and prevention, has been associated with proximal tubular dysfunction and gradual declines in kidney function in some patients — particularly those with pre-existing renal risk factors, longer treatment duration, or concurrent use of other nephrotoxic agents. Older antiretrovirals, including certain protease inhibitors, have also been linked to kidney stone formation and tubular injury.

This does not mean these medications should be avoided. For many people, the benefits of their regimen far outweigh the risks. But it does mean that kidney health monitoring deserves to be a deliberate and ongoing part of HIV care — not an afterthought.

What Standard Labs May Be Missing

The serum creatinine test, which appears on nearly every routine metabolic panel, is the most commonly used measure of kidney function. From creatinine, clinicians calculate an estimated glomerular filtration rate (eGFR) — a rough index of how well the kidneys are filtering blood. For most patients, this is where renal monitoring begins and ends.

The problem is that creatinine is a relatively insensitive marker, particularly in the early stages of kidney damage. A person can lose as much as 40 to 50 percent of their kidney function before creatinine levels rise enough to trigger clinical concern. By that point, the opportunity for early intervention may have already passed.

Several additional markers provide a more complete picture of renal health and are particularly relevant for people living with HIV:

• Urine albumin-to-creatinine ratio (uACR): Albuminuria — the presence of albumin protein in the urine — is one of the earliest detectable signs of kidney injury and a powerful predictor of CKD progression. It is not included in standard HIV monitoring panels unless specifically ordered.
• Urine protein-to-creatinine ratio (uPCR): Broader than uACR, this test captures a wider range of urinary proteins and can signal tubular dysfunction associated with certain antiretrovirals.
• Cystatin C: An alternative to creatinine for estimating GFR, cystatin C is less influenced by muscle mass — a factor that can artificially lower creatinine-based eGFR estimates in individuals with HIV-related muscle wasting.
• Urine beta-2 microglobulin and retinol-binding protein: These markers specifically reflect proximal tubular function and can detect early TDF-related tubular injury before eGFR declines.
• Phosphate levels: Hypophosphatemia (low blood phosphate) can be an early indicator of Fanconi syndrome, a form of tubular dysfunction linked to TDF toxicity.

If your current monitoring protocol does not include urinalysis with protein assessment at least annually, it may be worth initiating a direct conversation with your provider.

Questions Worth Asking at Your Next Appointment

Advocating for your own kidney health starts with informed dialogue. Consider raising the following with your HIV specialist or primary care provider:

1. "Has my kidney function been evaluated beyond creatinine and eGFR?" Request a urine albumin or protein assessment if one has not been performed recently.
2. "Does my current antiretroviral regimen carry any renal risk?" If you are taking TDF, ask whether your regimen could be transitioned to tenofovir alafenamide (TAF), a prodrug formulation that delivers lower systemic tenofovir concentrations and has demonstrated a more favorable renal safety profile in clinical trials.
3. "How often should I be screened given my personal risk factors?" Black patients, those with hypertension or diabetes, individuals with a family history of kidney disease, and those with lower baseline eGFR may benefit from more frequent monitoring.
4. "Are any of my other medications — prescribed or over-the-counter — affecting my kidneys?" NSAIDs like ibuprofen and naproxen, commonly used for pain management, can reduce renal blood flow and accelerate kidney damage in vulnerable individuals.

Lifestyle Modifications That Support Renal Function

Medication management and lab monitoring are only part of the equation. Several modifiable lifestyle factors have meaningful influence on kidney health over time.

Blood pressure control is arguably the single most important modifiable risk factor for CKD progression. Hypertension is both a cause and a consequence of kidney disease, and it is highly prevalent among people living with HIV. Achieving and maintaining a blood pressure below 130/80 mmHg — through dietary changes, regular physical activity, stress reduction, and medication when indicated — can substantially slow renal decline.

Blood glucose management is equally critical. Diabetes and pre-diabetes dramatically accelerate kidney damage, and people living with HIV face elevated metabolic risks due to both the virus and certain antiretroviral side effects. Routine HbA1c screening and early intervention are essential.

Hydration and dietary sodium also matter. Adequate fluid intake supports kidney filtration, while excessive sodium contributes to hypertension and fluid retention. A renal-supportive diet — rich in fruits, vegetables, and whole grains, and lower in processed foods and red meat — can reduce the kidney's workload over time. For those with more advanced CKD, a registered dietitian familiar with HIV care can provide tailored guidance on protein and potassium intake.

Avoiding nephrotoxic substances is another practical step. This includes limiting NSAID use, being cautious with herbal supplements (some of which contain compounds that can injure the kidneys), and discussing contrast dye procedures with your provider if you have reduced kidney function.

The Broader Picture: Integrating Renal Health Into Your HIV Care Plan

Kidney disease rarely announces itself with dramatic symptoms until it has progressed significantly. By the time fatigue, swelling, or changes in urination become noticeable, function may already be substantially compromised. This is precisely why proactive monitoring — rather than reactive response — must be the standard of care for people living with HIV.

The good news is that when kidney disease is caught early, its progression can often be slowed or even stabilized through a combination of medication optimization, lifestyle modification, and close clinical follow-up. The knowledge and tools exist. What is required now is the willingness to ask the right questions and insist on comprehensive care.

Your HIV care team is your partner in this process. Bringing informed, specific questions to your appointments signals that you are an active participant in your own health — and it creates the conditions for a more thorough, individualized approach to your long-term wellbeing.

This article is intended for general educational purposes and does not constitute medical advice. Always consult your healthcare provider regarding your specific health needs and treatment options.